Maine Healthcare
Compliance Guide

Maine presents a moderately favorable regulatory environment for healthcare companies, particularly those leveraging telehealth, though it maintains a clear stance on professional oversight and patient protection. The state has actively embraced telehealth expansion, especially following the COVID-19 pandemic, codifying many temporary flexibilities into permanent law. This commitment is evidenced by its comprehensive telehealth parity laws and its participation in interstate licensure compacts. Key regulatory bodies include the Maine Board of Licensure in Medicine, the Maine State Board of Nursing, and the Maine Board of Pharmacy, all of which play crucial roles in overseeing professional practice and ensuring compliance. The general business climate for healthcare operations is stable, with a strong emphasis on maintaining quality of care and patient access, particularly in rural areas. Recent legislative actions have focused on solidifying telehealth reimbursement, clarifying prescribing standards for controlled substances via telehealth, and addressing the opioid crisis through enhanced PDMP utilization. While Maine does not have an explicit statutory Corporate Practice of Medicine (CPOM) prohibition, the underlying principles are enforced through professional licensing board regulations and interpretations, requiring careful structuring of healthcare entities. Companies looking to operate in Maine must navigate these professional practice requirements, ensuring that clinical decision-making and patient care remain under the direct control of licensed professionals. The state's proactive approach to telehealth, combined with its traditional regulatory framework, necessitates a nuanced understanding for compliant operations.

Maine does not have an explicit statutory prohibition on the Corporate Practice of Medicine (CPOM) that broadly restricts non-physician ownership of medical practices. However, the principles underlying CPOM are implicitly enforced through various professional licensing statutes and regulations, particularly concerning professional independence, fee-splitting, and the unauthorized practice of medicine. The Maine Board of Licensure in Medicine, for instance, maintains that licensed physicians must retain ultimate control over clinical decision-making and patient care. While a lay entity may own the administrative assets of a medical practice, the professional services must be rendered by and under the direct supervision of licensed practitioners. This means that non-physicians can own healthcare businesses that provide administrative or management services to medical practices, but they cannot directly employ physicians or control their clinical judgment. This structure typically necessitates a Management Services Organization (MSO) model, where the MSO provides non-clinical services (e.g., billing, marketing, facility management) to a physician-owned professional entity, which employs the clinicians and delivers the medical services. For telehealth companies, medspas, dental practices, and wellness clinics, this implies that the entity directly providing professional medical, dental, or nursing services must be owned and controlled by licensed professionals in that field. For example, a dental practice must be owned by a licensed dentist or a professional entity composed of dentists. Similarly, a medical practice, even if operating solely via telehealth, must be structured to ensure that licensed physicians or other licensed practitioners retain clinical autonomy. Non-physicians can own the MSO that contracts with the professional entity, but they cannot own the professional entity itself or dictate clinical protocols. Fee-splitting prohibitions, found in regulations such as 32 M.R.S.A. § 3280, further reinforce these principles, preventing licensed professionals from sharing fees with unlicensed individuals or entities for patient referrals or professional services, unless specifically permitted by law (e.g., certain MSO arrangements that comply with fair market value compensation). Therefore, while not codified as a standalone CPOM statute, Maine's regulatory framework effectively upholds the spirit of CPOM by safeguarding professional independence and preventing the commercial exploitation of medical practice.

Maine has robust telehealth laws that largely align with in-person care standards, promoting its use for establishing provider-patient relationships and delivering a wide range of services. A provider-patient relationship can be established via telehealth, provided that the standard of care is met, and the provider has sufficient information to make an informed diagnosis and treatment plan. This is codified in 24-A M.R.S.A. § 4316-A, which mandates health insurance carriers to provide coverage for telehealth services at the same rate as in-person services. All modalities, including live interactive audio-visual (video), live interactive audio-only (phone), and asynchronous store-and-forward technologies, are generally permitted, provided they are clinically appropriate and meet the standard of care. The specific modality used must be adequate for the service being rendered. There are no specific telehealth registration requirements for providers beyond their standard professional licensure in Maine. However, out-of-state providers must be licensed in Maine to treat Maine patients, unless operating under specific interstate compacts (e.g., IMLCC, NLC, PSYPACT). Informed consent is a critical component of telehealth delivery in Maine. Prior to providing telehealth services, providers must obtain informed consent from the patient, which includes informing them of the nature of telehealth, potential risks, and the patient's right to withdraw consent. This consent should be documented in the patient's medical record. Maine law does not impose geographic restrictions on where a patient can receive telehealth services within the state, nor does it typically restrict providers based on their physical location within Maine, as long as they are licensed in the state. The Maine Board of Licensure in Medicine's Chapter 2, 'Rules for Licensure and Practice,' and Chapter 13, 'Rules for Telemedicine,' provide detailed guidance on the professional conduct and standards expected when delivering care via telehealth, emphasizing that the same standards of care apply as for in-person services.

Maine's prescribing rules for telehealth largely mirror those for in-person encounters, with specific considerations for controlled substances. For non-controlled substances, a valid provider-patient relationship, established either in-person or via telehealth, is sufficient for prescribing. For controlled substances, Maine generally permits prescribing via telehealth, provided the prescribing clinician adheres to federal and state regulations. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (21 U.S.C. § 829(e)) requires an in-person medical evaluation for prescribing controlled substances via the internet, with certain exceptions. Maine law (e.g., 22 M.R.S.A. § 2135-A) generally aligns with this, but during the public health emergency, federal waivers allowed for the prescribing of Schedule II-V controlled substances via telehealth without an initial in-person exam. While these federal waivers have largely expired or been modified, Maine's permanent telehealth rules allow for prescribing of controlled substances when a legitimate patient-practitioner relationship has been established, and the practitioner has conducted an appropriate medical evaluation, which can be via telehealth. However, practitioners should be aware of the evolving federal landscape regarding the Ryan Haight Act and DEA's proposed rules. All prescribers of controlled substances in Maine must register with the Maine Prescription Monitoring Program (PMP) and are required to check the PMP database before prescribing Schedule II, III, or IV controlled substances, as per 22 M.R.S.A. § 2173. This check is mandatory for initial prescriptions and at least every 90 days for ongoing therapy. There are no specific quantity or refill limitations via telehealth that differ from in-person prescribing, but all prescriptions must adhere to standard prescribing guidelines and medical necessity. Special rules apply to specific drug classes: for GLP-1s, testosterone, and stimulants, the prescribing clinician must ensure a thorough evaluation, appropriate diagnostic criteria, and ongoing monitoring, regardless of modality. For buprenorphine for Opioid Use Disorder (OUD), federal waivers have allowed for telehealth initiation, and Maine generally supports this within federal guidelines, emphasizing comprehensive treatment plans. Prescribers must exercise caution and adhere to the highest standards of care when prescribing controlled substances via telehealth, documenting all assessments and clinical justifications thoroughly.

Maine grants significant autonomy to Advanced Practice Registered Nurses (APRNs), including Nurse Practitioners (NPs), under a full practice authority model. As per 32 M.R.S.A. § 2102(2) and Chapter 3, 'Rules for the Licensure of Advanced Practice Registered Nurses,' NPs who meet specific education, certification, and practice experience requirements can practice independently without a collaborative practice agreement or physician supervision. This includes diagnosing, treating, prescribing medications (including controlled substances), and ordering and interpreting diagnostic tests, within their scope of practice and specialty. Physician Assistants (PAs) in Maine also operate with a high degree of autonomy, though historically under a 'supervision' model. However, recent legislative changes (e.g., 32 M.R.S.A. § 2595-A) have moved towards a 'collaboration' or 'delegation' model, reducing the direct supervisory burden and emphasizing team-based care. PAs are authorized to perform medical services delegated by a supervising or collaborating physician, which can include diagnosis, treatment, and prescribing. The specific scope is determined by the PA's education, experience, and the delegating physician's scope, documented in a practice agreement. For other mid-level providers, such as Certified Nurse Midwives (CNMs) and Certified Registered Nurse Anesthetists (CRNAs), Maine also grants full practice authority within their respective specialties. Delegation rules for Medical Assistants (MAs) in medspas or other clinical settings are strict. MAs can perform delegated tasks that fall within their training and competence, but these tasks typically do not include independent assessment, diagnosis, prescribing, or performing invasive procedures requiring professional judgment. Procedures like injections (e.g., Botox, fillers) or laser treatments generally require performance by or direct supervision of a physician, NP, or PA, depending on the specific procedure and the MA's training. The Maine Board of Licensure in Medicine and the Maine State Board of Nursing provide detailed guidance on delegation and supervision requirements, which must be strictly followed to avoid unauthorized practice of medicine or nursing.

Navigating business structures in Maine requires a keen understanding of its implicit Corporate Practice of Medicine (CPOM) doctrine and fee-splitting prohibitions. For healthcare companies, the Professional Corporation (PC) or Professional Limited Liability Company (PLLC) structure is typically mandated for the entity directly rendering professional medical services. Maine law (e.g., 13 M.R.S.A. § 701 et seq. for Professional Service Corporations) requires that professional services, such as medicine, dentistry, or nursing, be rendered by or under the supervision of licensed professionals. This means that the ownership of the professional entity must generally be restricted to licensed individuals in that profession. For example, a medical practice must be owned by physicians. The PC-MSO (Professional Corporation - Management Services Organization) model is the most common and compliant structure for allowing non-clinical investors or entities to participate in the financial success of a healthcare business. In this model, the PC/PLLC employs the licensed healthcare providers and delivers the clinical services, while the MSO, which can be owned by non-licensed individuals or entities, provides all non-clinical management, administrative, and operational services (e.g., billing, marketing, IT, human resources, facilities). The relationship between the PC/PLLC and the MSO is governed by a comprehensive Management Services Agreement (MSA). This MSA must clearly delineate the services provided by the MSO and the compensation structure. Compensation to the MSO must be for legitimate, fair market value services and cannot be based on a percentage of professional fees or patient referrals, as this would violate Maine’s fee-splitting prohibitions (e.g., 32 M.R.S.A. § 3280). The MSA should specify fixed fees, cost-plus arrangements, or other fair market value methodologies. It is crucial that the PC/PLLC retains ultimate control over all clinical decisions, patient care, and employment of clinical staff. The MSO should not interfere with the professional judgment of the licensed providers. For structuring ownership, non-licensed individuals or entities can own the MSO, but not the professional entity providing direct patient care. This separation ensures compliance with the spirit of CPOM and avoids issues related to the unauthorized practice of medicine. Careful drafting of the MSA and corporate documents is essential to clearly define roles, responsibilities, and compensation to withstand regulatory scrutiny.

Maine continues to refine its healthcare regulatory landscape, with several key developments and ongoing legislative considerations impacting telehealth, CPOM, and prescribing practices. In 2023-2024, significant efforts were made to solidify telehealth reimbursement parity, ensuring that services provided via telehealth are reimbursed at rates equivalent to in-person services, as per 24-A M.R.S.A. § 4316-A. This legislative commitment provides financial stability for telehealth providers. There has been ongoing discussion and potential legislative action regarding the permanent status of certain federal waivers related to controlled substance prescribing via telehealth, particularly in the wake of the federal Public Health Emergency (PHE) expiration. While Maine's current rules are generally permissive, providers should monitor federal DEA rulemaking regarding the Ryan Haight Act's applicability to telehealth. The state has also continued its participation and expansion in interstate licensure compacts. Maine is a member of the Interstate Medical Licensure Compact (IMLC), the Nurse Licensure Compact (NLC), and the Psychology Interjurisdictional Compact (PSYPACT), facilitating multi-state practice for eligible licensed professionals. This is a critical development for telehealth companies seeking to expand their provider networks. Recent board actions from the Maine Board of Licensure in Medicine and the Maine State Board of Nursing have reinforced the importance of maintaining the standard of care in telehealth, particularly concerning initial patient evaluations and appropriate documentation. Enforcement cases have focused on unlicensed practice and improper prescribing, underscoring the need for strict adherence to licensure and prescribing protocols. While no explicit new CPOM legislation has been introduced, the regulatory bodies continue to scrutinize business arrangements to ensure that clinical autonomy is preserved and that fee-splitting prohibitions are not violated. Companies should anticipate continued regulatory focus on patient safety, data privacy, and the appropriate use of technology in healthcare delivery.

For healthcare companies entering or expanding in Maine, a meticulous approach to compliance is paramount. Here's actionable guidance: 1. Licensure First: Ensure all clinicians providing services to Maine patients are appropriately licensed by their respective Maine professional board (e.g., Maine Board of Licensure in Medicine, Maine State Board of Nursing). If utilizing compacts (IMLC, NLC, PSYPACT), verify eligibility and proper compact privileges. 2. Establish Professional Entity: Form a Maine Professional Corporation (PC) or Professional LLC (PLLC) for the clinical services-providing entity. This entity must be owned by licensed professionals. 3. Implement MSO Structure: If non-licensed individuals or entities are involved in ownership or investment, establish a Management Services Organization (MSO) to contract with the PC/PLLC. Draft a robust Management Services Agreement (MSA) that clearly defines services, ensures fair market value compensation, and explicitly states the PC/PLLC's clinical autonomy. 4. Informed Consent: Develop a comprehensive telehealth informed consent process, documenting patient understanding of the modality, risks, and rights. 5. Prescribing Protocols: Implement strict protocols for prescribing, especially controlled substances, adhering to Maine's PMP requirements (22 M.R.S.A. § 2173) and federal Ryan Haight Act considerations. Ensure thorough patient evaluation and documentation. 6. Standard of Care: Train all providers on Maine's standard of care for telehealth, emphasizing that it mirrors in-person care. 7. Data Privacy: Ensure HIPAA compliance and adherence to Maine's specific data security and privacy laws. 8. Fee-Splitting Review: Regularly review all financial arrangements to ensure compliance with anti-kickback and fee-splitting prohibitions (e.g., 32 M.R.S.A. § 3280). Common pitfalls include inadequate licensure, poorly structured MSO agreements leading to CPOM violations, non-compliance with PMP checks, and insufficient informed consent. Licensing and setup can take several months; budget 3-6 months for professional licensure and corporate entity formation. Proactive engagement with legal counsel specializing in Maine healthcare law is strongly recommended to navigate these complexities effectively.